This finding is similar to other researchers' that reported a relatively low rate of PD‐L1 expression in SCLC up to 35.0% (with a very low cutoff point of 5% for PD‐L1 positive/negative expression), which was consistently lower than that in NSCLC [59]. Here, CD274 is linked to non-small cell lung carcinoma.